Amwill Health Care Ltd
BBSE:AMWILL43.75
INR
0.00
(0.00%)
ISIN
INE0U2L01017
Return %
Stock
S&P 500
1Y
-14.38
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- Full Time Employees
- 88
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- Bangalore India
- IPO Date
- Feb 12, 2025
- Website
- amwillhealthcare.com
- Similar Companies
- Business
- Amwill Health Care Ltd is a specialty pharmaceutical and derma-cosmetic company based in India that specializes in the development, marketing, and distribution of prescription-based dermatological, trichological, cosmeceutical, and nutraceutical formulations. The company provides a diversified portfolio of therapeutic and personal care products categorized into dermatology solutions, such as topical anti-acne gels, skin lightening and depigmentation creams, broad-spectrum sunscreens, deep-hydrating emollients, skin barrier repair lotions, and topical antifungal formulations; trichology and hair care products, such as anti-dandruff solutions, hair growth and revitalizing serums, anti-hair fall lotions, and specialized peptide shampoos; cosmeceuticals and aesthetic care, including chemical peels, skin brightening serums, under-eye revitalizers, and therapeutic facial cleansers; and nutraceuticals and wellness supplements, such as oral collagen peptides, glutathione effervescent tablets, biotin complexes, and multivitamin supplements for hair, skin, and nail health. Amwill Health Care Ltd distributes its products primarily through ethical prescription channels by partnering with dermatologists, trichologists, cosmetologists, aesthetic clinics, hospital networks, retail pharmacy chains, and direct-to-consumer e-commerce platforms across India. In recent developments, the company underwent a corporate restructuring and transitioned to a public limited company, subsequently completing an initial public offering to list its shares on the BSE SME platform under the ticker AMWILL to finance its working capital, expand research and distribution capabilities, and bolster brand awareness. Within the past two years, Amwill Health Care Ltd has expanded its product catalog with new launches in advanced anti-aging peptide serums, microbiome-balancing skin treatments, and clinical-grade photoprotection lines. Additionally, the company has entered into strategic manufacturing alliances with WHO-GMP-certified contract development and manufacturing organizations to support increased production capacity and has expanded its sales and marketing network across Tier-II and Tier-III cities in northern and eastern India. Amwill Health Care Ltd was incorporated in 2016 and is headquartered in Bengaluru, Karnataka, India.